July / August 2008
PRODUCTS | back to list
AT-HOME HEART FAILURE MONITOR FOR CONGESTIVE HEART FAILURE PATIENTS
The Bioheart 3370 Heart Failure Monitor, from Bioheart, Inc., is an interactive and simple-to-use at-home intelligent device. It is designed specifically to improve available healthcare to patients outside hospitals who are suffering from heart failure. The device, manufactured by RTX Healthcare A/S (Denmark), has 510K market clearance from the U.S. Food and Drug Administration for marketing in the U.S. and CE mark approval for marketing in Europe and other countries that follow this mark. The company is planning to begin immediate commercial distribution. The monitor engages patients through personalized daily interactions and questions, while collecting vital signs and transmitting the information directly into a database. It is available in both a wireless configuration and through hook-up to regular telephone lines. The data is regularly monitored by a remotely located medical professional, who watches for any abnormal readings that may signal a change in the patient’s health status. These changes are reported back to the treating physician. “Remote monitoring of heart failure patients forms a cornerstone of heart failure disease management, enhancing the opportunity to avoid episodes of worsening heart failure and emergency hospitalizations,” said William Abraham, professor of internal medicine and director of the Division of Cardiovascular Medicine at Ohio State University Medical Center. “In the long run, our goal is to improve quality of life and keep patients out of the hospital.” The monitor collects data from a range of vital sign monitoring devices, a weight scale and a voice-activated heart failure status questionnaire, and provides for secure data transmission to an HTTP server on the Internet. The monitor is designed with unique features that make the device state-of-the-art for system integrators working the area of home monitoring, e-health and remote disease management. Regular data input and monitoring enables the health care team to detect signs and symptoms of change as they occur.
Bioheart, Inc.
RRC #4037
RRC #4037
